Home › Psoriatic Arthritis › Ohio
Psoriatic Arthritis clinical trials in Ohio
14 studies for Psoriatic Arthritis are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Paramount Medical Research & Consulting, Middleburg Heights
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321873A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Middleburg Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Paramount Medical Research & Consulting, LLC, Middleburg Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07286058A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- MetroHealth Medical Center /ID# 262377, Cleveland
- Cleveland Clinic - Cleveland /ID# 276655, Cleveland
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Metrohealth Medical Center, Cleveland
- and 2 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 144, Vandalia
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT07290036A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06454188Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Paramount Medical Research and Consulting /ID# 272757, Middleburg Heights
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Cincy Arthritis, Blue Ash
- Southern Ohio Rheumatology, Wheelersburg
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 9, 2025 · NCT05669833IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 29, 2023 · NCT05883371From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.